Journey Medical (DERM) Income towards Parent Company (2020 - 2026)
Journey Medical's (DERM) quarterly Income towards Parent Company came in at -$2.2 million in Q1 2026, up 45.25% YoY from -$1.5 million in Q1 2025, and down 81.45% on a QoQ basis from -$1.2 million in Q4 2025.
Journey Medical (DERM) Income towards Parent Company (2020 - 2026) Analysis & Trends
Journey Medical (DERM) has 7 years of Income towards Parent Company data on file, last reported at -$2.2 million in Q1 2026.
- Quarterly Income towards Parent Company rose 45.25% year-over-year to -$2.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$9.6 million (down 16.11% YoY) and the FY2025 annual result came in at -$11.4 million, up 22.21% from the prior year.
- Income towards Parent Company retreated to -$2.2 million in Q1 2026, from -$1.2 million in the prior quarter.
- In the past five years, Income towards Parent Company ranged from a high of $16.8 million in Q3 2023 to a low of -$10.6 million in Q4 2022.
- A 5-year average of -$3.6 million and a median of -$3.4 million in 2024 frame the typical range for Income towards Parent Company.
- The widest YoY moves for Income towards Parent Company: up 266.56% in 2023, down 635.56% in 2023.
- Tracing DERM's Income towards Parent Company over 5 years: stood at -$10.6 million in 2022, then jumped by 79.86% to -$2.1 million in 2023, then jumped by 173.82% to $1.6 million in 2024, then slumped by 177.69% to -$1.2 million in 2025, then slumped by 81.45% to -$2.2 million in 2026.
- The last three Income towards Parent Company figures came in at -$2.2 million (Q1 2026), -$1.2 million (Q4 2025), and -$2.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.81 Bn | 42.84 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.29 Bn | 39.63 Bn | 2.15 Bn |
| 3 | Zoetis | 31.59 Bn | 29.91 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.88 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.24 Bn | 19.58 Bn | 683.80 Mn |
| 6 | Viatris | 18.79 Bn | 17.91 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.71 Bn | 15.32 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.09 Bn | 11.56 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Journey Medical | 205.93 Mn | 180.28 Mn | 12.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -312,000.00 |
| Mar 31, 2026 | -2.23 Mn |
| Dec 31, 2025 | -1.23 Mn |
| Sep 30, 2025 | -2.32 Mn |
| Jun 30, 2025 | -3.80 Mn |
| Mar 31, 2025 | -4.07 Mn |
| Dec 31, 2024 | 1.58 Mn |
| Sep 30, 2024 | -2.39 Mn |
| Jun 30, 2024 | -3.36 Mn |
| Mar 31, 2024 | -10.44 Mn |
| Dec 31, 2023 | -2.14 Mn |
| Sep 30, 2023 | 16.79 Mn |
| Jun 30, 2023 | -8.36 Mn |
| Mar 31, 2023 | -10.14 Mn |
| Dec 31, 2022 | -10.64 Mn |
| Sep 30, 2022 | -10.08 Mn |
| Jun 30, 2022 | -7.53 Mn |
| Mar 31, 2022 | -1.38 Mn |
| Dec 31, 2021 | -21.75 Mn |
| Sep 30, 2021 | -10.65 Mn |